Tafinlar 50 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FNWMA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,836
Award facts
- Contract value 100% obligated
- $13,836.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a $13,836.26 delivery order by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of TAFINLAR 50 mg capsules (120-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by October 6, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
TAFINLAR is an oncology medication used in the treatment of certain melanomas and other cancers, reflecting the scope of specialty pharmaceutical products that AmerisourceBergen supplies to federal healthcare systems. As a major pharmaceutical distributor serving the Department of Defense and military healthcare networks, AmerisourceBergen leverages its comprehensive IDC vehicle to fulfill medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The DLA Troop Support Medical contract enables the company to support Defense Health Agency operations and other government healthcare systems globally, positioning this delivery order within the broader federal pharmaceutical supply chain supporting military and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FNWMA?
SPE2DB25FNWMA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNWMA worth?
The government has obligated $13,836 on SPE2DB25FNWMA.
Is contract SPE2DB25FNWMA an order under another contract?
Yes. SPE2DB25FNWMA is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWMA competed?
The extent of competition for SPE2DB25FNWMA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award